Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.
PAGP, EIX, SNX, CNMD and PCG stand out with attractive EV-to-EBITDA ratios and strong earnings outlooks.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Patrick J. Beyer CEO | XSTU Exchange | US2074101013 ISIN |
| US Country | 3,900 Employees | 15 Sep 2025 Last Dividend | 10 Sep 2001 Last Split | 23 Jul 1987 IPO Date |
CONMED Corporation is an influential player in the medical technology sphere, with a focus on the development, manufacturing, and global sales of surgical devices and related equipment. This company caters to a broad spectrum of surgical procedures, providing innovative solutions that aim to enhance clinical outcomes for patients around the world. Operating under various esteemed brands, including Hall, CONMED Linvatec, Concept, and Shutt, the corporation has established a strong reputation for quality and innovation since its inception in 1970. Headquartered in Largo, Florida, CONMED Corporation takes a direct approach to marketing its products, targeting hospitals, surgery centers, and other healthcare institutions while also leveraging medical specialty distributors for broader reach.